Szilan Fodor is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-sclerostin antibodies. With a total of 2 patents to his name, Fodor's work is paving the way for advancements in therapeutic applications.

Latest Patents

Fodor's latest patents include innovative approaches to anti-sclerostin antibodies. The first patent focuses on C-terminal anti-sclerostin antibody variants, which generally relate to antibodies having C-terminal modifications and compositions comprising such antibodies. The second patent also addresses C-terminal antibody variants, emphasizing the same modifications and their potential applications.

Career Highlights

Fodor is currently employed at Amgen Inc., a leading biotechnology company known for its commitment to developing innovative therapies. His work at Amgen has allowed him to explore and expand the possibilities of antibody-based treatments.

Collaborations

Some of Fodor's coworkers include Zhe Huang and Jennitte LeAnn Stevens, who contribute to the collaborative environment at Amgen. Their combined expertise fosters innovation and drives the development of new therapeutic solutions.

Conclusion

Szilan Fodor's contributions to the field of anti-sclerostin antibodies highlight his role as an influential inventor in biotechnology. His patents and work at Amgen Inc. reflect a commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.